Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer

Shaun J. Trecarten, Robert S. Svatek

Research output: Contribution to journalArticlepeer-review

Abstract

In the SELENIB trial, selenium and vitamin E were compared with placebo as chemoprevention for non-muscle-invasive bladder cancer (NMIBC). No difference versus placebo was observed in recurrence-free interval (RFI) with selenium, but vitamin E was associated with worse RFI. Selenium and vitamin E cannot be recommended in chemoprevention for NMIBC. Furthermore, patients with NMIBC taking supplemental vitamin E should be made aware of its potential association with worse RFI.

Original languageEnglish (US)
Pages (from-to)458-459
Number of pages2
JournalNature Reviews Urology
Volume21
Issue number8
DOIs
StatePublished - Aug 2024

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Cite this